CAPTRUST FINANCIAL ADVISORS

Position in FTRE — Fortrea Holdings Inc.

CIK 1512024 RALEIGH, NC

Position in FTRE

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,024,751

+$777,355 QoQ

Shares Held

116,365

-12.1% QoQ

Ownership

0.122%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#83

of 334 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 14% Shared 0% None 86%

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $169,003,876 across 125 Biotechnology names. FTRE ranks #17 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	36,464	$22,736,762
2	RPRX	Royalty Pharma plc	337,298	$18,912,298
3	VRTX	Vertex Pharmaceuticals Inc / Ma	35,471	$17,619,509
4	EXEL	Exelixis, Inc.	303,042	$16,488,515
5	LGND	Ligand Pharmaceuticals Inc	34,607	$10,938,926
6	HALO	Halozyme Therapeutics, Inc.	125,946	$9,857,793
7	CELC	Celcuity Inc.	71,445	$7,474,575
8	INCY	Incyte Corp	50,301	$5,702,121

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,024,751	116,365	-12.1%	Shares	Sole	2026-08-13
2026-03-31	$1,247,396	132,420	+32.7%	Shares	Sole	2026-05-15
2025-12-31	$1,721,567	99,801	+180.2%	Shares	Sole	2026-02-17
2025-09-30	$299,911	35,619	-17.5%	Shares	Sole	2025-11-19
2025-06-30	$213,165	43,151	+271.5%	Shares	Sole	2025-08-15
2025-03-31	$87,700	11,616	-5.1%	Shares	Sole	2025-05-15
2024-12-31	$228,257	12,239	-6.8%	Shares	Sole	2025-02-14
2024-09-30	$262,700	13,135	-45.6%	Shares	Sole	2024-11-14
2024-06-30	$563,917	24,161	-16.4%	Shares	Sole	2024-08-15
2024-03-31	$1,160,206	28,904	-14.4%	Shares	Sole	2024-05-15
2023-12-31	$1,178,991	33,782	-13.4%	Shares	Sole	2024-02-14
2023-09-30	$1,115,781	39,027	—	Shares	Sole	2023-11-15
No filing history on record for this holder in this stock.